KALV Kalvista Pharmaceuticals Inc

KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.

$26.17  +0.94 (3.73%)
As of 04/13/2021 15:59:55 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/09/2015
Outstanding shares:  24,308,191
Average volume:  425,698
Market cap:   $613,295,659
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    483497103
ISIN:        US4834971032
Sedol:      BD06CS0
Valuation   (See tab for details)
PE ratio:   -35.25
PB ratio:   7.76
PS ratio:   85.26
Return on equity:   -47.53%
Net income %:   -386.96%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy